If Roche wants a truly revolutionary diagnostics firm to acquire they should acquire Trovagene. TROV figured out how to diagnose and monitor cancer and infectious diseases in urine. Their first urine based cancer test is launching in Jan 2013 with many more being rolled out in 2013. TROV being brought forward by elite scientists, dr's, professors and the whole old management team from Sequenom just took over the company. They have 40+ patents approved and 50+ pending for diagnosing cancer and diseases in urine. They also do transplant monitoring in urine and prenatal analysis using urine. They have been working on this for 10 years and are commercializing now. TROV will be acquired super quick I predict bc they are a game changer.